β¨ Medicines Notices
1056
NEW ZEALAND GAZETTE
No. 36
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Colistin sulphomethate sodium 0.24 mg (3,000,000 IU), erythromycin glucoheptonate 0.65 g equivalent to 0.5 g erythromycin base | Bone cement, powder component | Pfizer GmbH, Karlsruhe, Germany | Antibiotic Simplex |
| Deflazacort 6 mg, 30 mg | Tablets | Gruppo Lepetit S p A., Anagni (Frosinone), Italy | Calcort |
| Cajuput oil 20 mg, camphor 20 mg, eucalyptus oil 20 mg, melaleuca alternifolia oil 20 mg, menthol 20 mg, methyl salicylate 120 mg, peppermint oil 20 mg in 30 g, 60 g and 120 g | Ointment | Ramprie Laboratories, Division of Narwhal Pty Limited, Welshpool, Western Australia, Australia | Mt Romance Emu Oil Deep Rub |
| Calcium carbonate 317 mg equivalent to 127 mg elemental calcium, magnesium hydroxide 64 mg equivalent to 26 mg elemental magnesium | Tablet, chewable | Adams Brands Manufacturing, Division Warner Lambert Canada Inc., Scarborough, Ontario, Canada | Mylanta Rolltabs (Fruit Flavour) |
| Calcium carbonate 317 mg equivalent to 127 mg elemental calcium, magnesium hydroxide 64 mg equivalent to 26 mg elemental magnesium | Tablet, chewable | Adams Brands Manufacturing, Division Warner Lambert Canada Inc., Scarborough, Ontario, Canada | Mylanta Rolltabs (Peppermint Flavour) |
| Calcium carbonate 317 mg equivalent to 127 mg elemental calcium, magnesium hydroxide 64 mg equivalent to 26 mg elemental magnesium | Tablet, chewable | Adams Brands Manufacturing, Division Warner Lambert Canada Inc., Scarborough, Ontario, Canada | Mylanta Rolltabs (Spearmint Flavour) |
| Tamsulosin hydrochloride 0.4 mg | Capsule | Yamanouchi Pharmaceutical Co Limited, Nishine-cho, Iwate-gun, Iwate-ken, Japan | Omnic 0.4 |
| Ranitidine bismuth citrate 400 mg | Tablet | Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom | Pylorid |
| Guaiphenesin 20 mg/mL in 100 mL, 200 mL | Syrup | Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia | Robitussin EX |
Dated this 12th day of April 1996.
G. R. BOYD, Acting Assistant General Manager, Health Regulation & Protection, pursuant to delegation given by the Minister of Health on 18 January 1996.
g02520
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Captopril 37.5 mg | Tablet | Bristol-Myers Squibb Pharmaceuticals Limited, Moreton, Wirral, Merseyside, England and Bristol-Myers Squibb Australia Pty Limited, Noble Park, Victoria, Australia | Capoten D |
| Carboxymethylcellulose 5 mg/mL in 0.4 mL | Drops, eye | Allergan Optical, Allergan Inc., Waco, Texas, United States of America | Cellufresh |
| Triptorelin acetate 4 mg equivalent to 3.75 mg triptorelin | Solution for injection, prefilled syringe | Ferring AB., Malmo, Sweden and Ferring Arzneimittel GmbH., Keil, Germany | Decapeptyl-CR |
| Isosorbide mononitrate 120 mg | Tablet, modified release | Astra Pharmaceutical Production AB., Sodertalje, Sweden | Imdur Durules |
| Omeprazole 20 mg | Capsule | Astra Pharmaceutical Production AB., Sodertalje, Sweden | Losec |
| Omeprazole sodium 42.6 mg equivalent of 40 mg omeprazole in 10 mL | Powder for injection (ampoule) and diluent (ampoule) | Astra Pharmaceutical Production AB., Sodertalje, Sweden | Losec IV |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1996, No 36
NZLII —
NZ Gazette 1996, No 36
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of Medicines
π₯ Health & Social Welfare12 April 1996
Medicines, Distribution, Consent, Pharmaceuticals, Health Regulation
- G. R. Boyd, Acting Assistant General Manager, Health Regulation & Protection
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines, Distribution, Consent, Changed Medicines, Pharmaceuticals